Healthcare Equipment and Supplies
Company Overview of Senseonics, Inc.
Senseonics, Inc., a medical device company, engages in the development and commercialization of transformative glucose monitoring products for people with diabetes. The company’s portfolio includes Continuous Glucose Monitoring System, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver for obtaining continuous glucose readings during the 180-day study duration. Its sensor technology is also used to detect other chemical species, such as oxygen, carbon dioxide, pH, nitric oxide, lactate, and anesthetic gases. The company ...
20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
Founded in 1996
Key Executives for Senseonics, Inc.
Chief Executive Officer, President, Consultant and Director
Vice President of Operations, Quality and Regulatory
Vice President of Clinical Sciences
Compensation as of Fiscal Year 2014.
Senseonics, Inc. Key Developments
Senseonics, Inc. Appoints R. Don Elsey as Chief Financial Officer
Jan 9 15
Senseonics, Inc. announced the appointment of R. Don Elsey as the company's new Chief Financial Officer. Prior to joining the company, Don served from May 2014 to February 2015 as the CFO of Regado Biosciences. From December 2013 to March 2014, he was the CFO of LifeCell, Inc.
Oxford Finance LLC Announces Closing of $10 Million Senior Secured Term Loan Agreement with Senseonicsc
Aug 21 14
Oxford Finance LLC has announced the closing of a $10 million senior secured term loan agreement with Senseonics, Inc. Proceeds of the loan will be used to fund the ongoing development of an implantable continuous glucose monitoring system for people with diabetes.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries